Related Experiment Videos
Acute renal failure after intravenous immunoglobulin therapy
A M Pasatiempo1, J A Kroser, M Rudnick
1Department of Medicine, Medical College Hospital, Philadelphia, PA 19129.
The Journal of Rheumatology
|February 1, 1994
Summary
Intravenous immunoglobulin (IVIG) therapy can cause acute kidney injury in some patients. This renal dysfunction was transient and reversible after stopping IVIG treatment.
Area of Science:
- Nephrology
- Immunology
- Pharmacology
Background:
- Intravenous immunoglobulin (IVIG) is a critical therapy for various autoimmune and immune deficiency disorders.
- Understanding potential adverse effects of IVIG is crucial for patient safety and treatment management.
Observation:
- Three patients developed acute renal failure during or shortly after receiving IVIG therapy.
- The renal dysfunction was temporally associated with IVIG administration.
- No specific IVIG preparation or dosage was linked to the observed renal events.
Findings:
- Laboratory markers of kidney function, such as blood urea nitrogen (BUN) and creatinine, showed transient elevations.
- Renal impairment resolved within 8–14 days after discontinuing IVIG.
- One patient experienced severe renal dysfunction, requiring hemodialysis due to azotemia, heart failure, hyponatremia, hyperkalemia, and metabolic acidosis.
Implications:
- Clinicians should monitor renal function in patients receiving IVIG.
- Early recognition and discontinuation of IVIG may lead to reversible kidney injury.
- Further research into the mechanisms of IVIG-induced nephrotoxicity is warranted.